scholarly journals Magnetic Resonance Imaging Based Delta Radiomics As Biomarker for Intermediate Risk Prostate Cancer Treated By Hypofractionated Stereotactic Boost: A Phase II CKNO PRO Ancillary Study

2019 ◽  
Vol 105 (1) ◽  
pp. E274-E275
Author(s):  
A. Escande ◽  
N. Betrouni ◽  
E. Tresch ◽  
B. Renard ◽  
O. Colot ◽  
...  
Keyword(s):  
Magnetic Resonance Imaging ◽  
Prostate Cancer ◽  
Magnetic Resonance ◽  
Phase Ii ◽  
Intermediate Risk ◽  
Resonance Imaging ◽  
Ancillary Study ◽  
Risk Prostate Cancer

scholarly journals Plan quality for high-risk prostate cancer treated with high field magnetic resonance imaging guided radiotherapy

2018 ◽  
Vol 7 ◽  
pp. 1-8 ◽  
Author(s):  
Rasmus Lübeck Christiansen ◽  
Christian Rønn Hansen ◽  
Rikke Hedegaard Dahlrot ◽  
Anders Smedegaard Bertelsen ◽  
Olfred Hansen ◽  
...  
Keyword(s):  
Magnetic Resonance Imaging ◽  
Prostate Cancer ◽  
High Risk ◽  
Magnetic Resonance ◽  
High Field ◽  
Plan Quality ◽  
Resonance Imaging ◽  
High Risk Prostate Cancer ◽  
Risk Prostate Cancer
Sign in / Sign up

Export Citation Format

Share Document